ArticleMucosal immunology2017

MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.

C Benito-Villalvilla et al.PubMed ↗Publisher ↗

No numbers read from the abstract.